Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N B Liabakk

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Gynecologic and Obstetric Investigation|January 1, 1996
Detection of soluble receptors for tumor necrosis factor, interleukin-2 and interleukin-6 in retroplacental serum from normal pregnant womenE Lien, N B Liabakk, R Austgulen
Journal of Immunological Methods|December 5, 1990
A rapid and sensitive immunoassay for tumor necrosis factor using magnetic monodisperse polymer particlesN B Liabakk, K Nustad, T Espevik
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 20, 1992
[Secretion of soluble receptors for tumor necrosis factor. An immunologic buffer mechanism during normal pregnancy?]R Austgulen, N B Liabakk, T Espevik
Journal of Reproductive Immunology|August 1, 1992
Soluble TNF receptors in amniotic fluid and in urine from pregnant womenR Austgulen, N B Liabakk, M Brockhaus, et al.
Cytometry|December 18, 2001
Nonlabeled secondary antibodies augment/maintain the binding of primary, specific antibodies to cell membrane antigensJ Lamvik, H Hella, N B Liabakk, et al.
Pediatric Research|January 1, 1993
Increased levels of soluble tumor necrosis factor-alpha receptors in serum from pregnant women and in serum and urine samples from newbornsR Austgulen, N B Liabakk, E Lien, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1990
The role of TNF in regulation of cell functionT Espevik, R Shalaby, N B Liabakk, et al.
Cancer Research|January 1, 1996
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancerN B Liabakk, I Talbot, R A Smith, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 1, 1994
Increased levels of cytokines and cytokine activity modifiers in normal pregnancyR Austgulen, E Lien, N B Liabakk, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 1, 1995
Soluble tumor necrosis factor receptor in serum and urine throughout normal pregnancy and at deliveryK J Arntzen, N B Liabakk, G Jacobsen, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Gynecologic and Obstetric Investigation|January 1, 1996
Detection of soluble receptors for tumor necrosis factor, interleukin-2 and interleukin-6 in retroplacental serum from normal pregnant womenE Lien, N B Liabakk, R Austgulen
Journal of Immunological Methods|December 5, 1990
A rapid and sensitive immunoassay for tumor necrosis factor using magnetic monodisperse polymer particlesN B Liabakk, K Nustad, T Espevik
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 20, 1992
[Secretion of soluble receptors for tumor necrosis factor. An immunologic buffer mechanism during normal pregnancy?]R Austgulen, N B Liabakk, T Espevik
Journal of Reproductive Immunology|August 1, 1992
Soluble TNF receptors in amniotic fluid and in urine from pregnant womenR Austgulen, N B Liabakk, M Brockhaus, et al.
Cytometry|December 18, 2001
Nonlabeled secondary antibodies augment/maintain the binding of primary, specific antibodies to cell membrane antigensJ Lamvik, H Hella, N B Liabakk, et al.
Pediatric Research|January 1, 1993
Increased levels of soluble tumor necrosis factor-alpha receptors in serum from pregnant women and in serum and urine samples from newbornsR Austgulen, N B Liabakk, E Lien, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1990
The role of TNF in regulation of cell functionT Espevik, R Shalaby, N B Liabakk, et al.
Cancer Research|January 1, 1996
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancerN B Liabakk, I Talbot, R A Smith, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 1, 1994
Increased levels of cytokines and cytokine activity modifiers in normal pregnancyR Austgulen, E Lien, N B Liabakk, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 1, 1995
Soluble tumor necrosis factor receptor in serum and urine throughout normal pregnancy and at deliveryK J Arntzen, N B Liabakk, G Jacobsen, et al.
Pageof 3